Abstract
Eighty three patients of infected total hip arthroplasty (THA) treated by implant removal and staged revision were retrospectively analyzed. Clinical characteristics and treatment outcomes were compared between three groups: 17 one-stage revisions (one-stage group), 44 two-stage revisions with second stage reimplantation (two-stage reimplanted group), and 22 planned two-stage but no reimplantation (two-stage non-reimplanted group). The rate of infection control was 82% (14/17) in the one-stage group, 75% (33/44) in the two-stage reimplanted group, and 68% (15/22) in the two-stage non-reimplanted group (P=0.60). The mean of latest Harris hip score was 77, 60, and 58 (P=0.14), and the UCLA activity score was 4.0, 4.2, and 3.6 (P=0.74) for each group, respectively. Results of this study suggest that one-stage revision arthroplasty can be a treatment option in selected cases of infected THA with a satisfactory infection control rate and functional outcomes comparable to those of two-stage revision.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
